The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
2020 American College of Rheumatology Guideline for the Management of Gout
Open accessAbstract
Objective: To provide guidance for the management of gout, including indications for and optimal use of urate‐lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations. Methods: Fifty‐seven population, intervention, comparator, and outcomes questions were developed, followed by a systematic literature review, including network meta‐analyses with ratings of the available evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, and patient input. A group consensus process was used to compose the final recommendations and grade their strength as strong or conditional. Results: Forty‐two recommendations (including 16 strong recommendations) were generated. Strong recommendations included initiation of ULT for all patients with tophaceous gout, radiographic damage due to gout, or frequent gout flares; allopurinol as the preferred first‐line ULT, including for those with moderate‐to‐severe chronic kidney disease (CKD; stage >3); using a low starting dose of allopurinol (≤100 mg/day, and lower in CKD) or febuxostat (<40 mg/day); and a treat‐to‐target management strategy with ULT dose titration guided by serial serum urate (SU) measurements, with an SU target of <6 mg/dl. When initiating ULT, concomitant antiinflammatory prophylaxis therapy for a duration of at least 3–6 months was strongly recommended. For management of gout flares, colchicine, nonsteroidal antiinflammatory drugs, or glucocorticoids (oral, intraarticular, or intramuscular) were strongly recommended. Conclusion: Using GRADE methodology and informed by a consensus process based on evidence from the current literature and patient preferences, this guideline provides direction for clinicians and patients making decisions on the management of gout.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationSacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21772 · Cited by 1,536
Self-citationZhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055269 · Cited by 1,407
Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hung, S.-I., Chung, W.-H., Liou, L.-B., Chu, C.-C., Lin, M., Huang, H.-P., Lin, Y.-L., Lan, J.-L., Yang, L.-C., Hong, H.-S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409500102 · Cited by 1,284
Chen‐Xu, M., Yokose, C., Rai, S. K., Pillinger, M. H., & Choi, H. K. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40807 · Cited by 1,072
Self-citationCardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
White, W. B., Saag, K. G., Becker, M. A., Borer, J. S., Gorelick, P. B., Whelton, A., Hunt, B., Castillo, M., & Gunawardhana, L. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710895 · Cited by 909
The GRADE Working Group clarifies the construct of certainty of evidence
Hultcrantz, M., Rind, D., Akl, E. A., Treweek, S., Mustafa, R. A., Iorio, A., Alper, B. S., Meerpohl, J. J., Murad, M. H., Ansari, M. T., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.05.006 · Cited by 853
Self-citationAsymptomatic hyperuricemia. Risks and consequences in the normative aging study
Campion, E. W., Glynn, R. J., & Delabry, L. O. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90441-4 · Cited by 851
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Study, L. C., Köttgen, A., CARDIoGRAM Consortium, DIAGRAM Consortium, ICBP Consortium, MAGIC Consortium, Albrecht, E., Teumer, A., Vitart, V., Krumsiek, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2500 · Cited by 836
González-Galarza, F. F., Takeshita, L. Y. C., Santos, E. J. M., Kempson, F., Maia, M. H. T., Silva, A. L. S. D., Silva, A. L. T. E., Ghattaoraya, G. S., Alfirevic, A., Jones, A. R., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1166 · Cited by 737
Khanna, D., Khanna, P. P., Fitzgerald, J. D., Singh, M. K., Bae, S., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21773 · Cited by 728
Self-citationSchumacher, H. R., Becker, M. A., Wortmann, R. L., MacDonald, P. A., Hunt, B., Streit, J., Lademacher, C., & Joseph‐Ridge, N. (2008) · Arthritis Care & Research · doi:10.1002/art.24209 · Cited by 638
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
Kuo, C.-F., Grainge, M. J., Mallen, C., Zhang, W., & Doherty, M. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204463 · Cited by 622
Comparison of drug adherence rates among patients with seven different medical conditions
Briesacher, B. A., Andrade, S. E., Fouayzi, H., & Chan, K. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.4.437 · Cited by 587
Jordan, K. M., Cameron, J. S., Snaith, M., Zhang, W., Doherty, M., Seckl, J., Hingorani, A., Jaques, R., & Nuki, G. (2007) · Rheumatology · doi:10.1093/rheumatology/kem056a · Cited by 552
Effect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic gout
Perez‐Ruiz, F., Calabozo, M., Pijoan, J. I., Herrero‐Beites, A. M., & Ruibal, A. (2002) · Arthritis Care & Research · doi:10.1002/art.10511 · Cited by 454
Shoji, A., Yamanaka, H., & Kamatani, N. (2004) · Arthritis Care & Research · doi:10.1002/art.20405 · Cited by 438
Choi, J. W. J., Ford, E. S., Gao, X., & Choi, H. K. (2008) · Arthritis Care & Research · doi:10.1002/art.23245 · Cited by 418
Tassaneeyakul, W., Jantararoungtong, T., Chen, P., Lin, P.-Y., Tiamkao, S., Khunarkornsiri, U., Chucherd, P., Konyoung, P., Vannaprasaht, S., Choonhakarn, C., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328330a3b8 · Cited by 401
Doherty, M., Jenkins, W., Richardson, H., Sarmanova, A., Abhishek, A., Ashton, D., Barclay, C., Doherty, S., Duley, L., Hatton, R., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32158-5 · Cited by 390
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kimura, K., Hosoya, T., Uchida, S., Inaba, M., Makino, H., Maruyama, S., Ito, S., Yamamoto, T., Tomino, Y., Ohno, I., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.028 · Cited by 383
Schlesinger, N., Alten, R. E., Bardin, T., Schumacher, H. R., Bloch, M., Gimona, A., Krammer, G., Murphy, V., Richard, D., & So, A. K. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200908 · Cited by 359
Dessein, P. H., Shipton, E. A., Stanwix, A. E., Joffe, B. I., & Ramokgadi, J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.7.539 · Cited by 335
FRUCTOSE-INDUCED HYPERURICÆMIA
Stirpe, F., Della Corte, E., Bonetti, E., Abbondanza, A., Abbati, A., & De Stefano, F. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92269-5 · Cited by 333
Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.
Borstad, G. C., Bryant, L. R., Abel, M. P., Scroggie, D. A., Harris, M. D., & Alloway, J. A. (2004) · PubMed · Cited by 328
Janssens, H. J., Janssen, M., van de Lisdonk, E. H., van Riel, P. L., & van Weel, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60799-0 · Cited by 317
So, A., De Meulemeester, M., Pikhlak, A., Yücel, A. E., Richard, D., Murphy, V., Arulmani, U., Sallstig, P., & Schlesinger, N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27600 · Cited by 315
Fructose-Rich Beverages and Risk of Gout in Women
Choi, H. K., Willett, W., & Curhan, G. (2010) · JAMA · doi:10.1001/jama.2010.1638 · Cited by 314
Stamp, L. K., Taylor, W. J., Jones, P. B., Dockerty, J. L., Drake, J., Frampton, C., & Dalbeth, N. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34488 · Cited by 296
Self-citationSarawate, C. A., Brewer, K. K., Yang, W., Patel, P. A., Schumacher, H. R., Saag, K. G., & Bakst, A. W. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.7.925 · Cited by 292
Gout: why is this curable disease so seldom cured?
Doherty, M., Jansen, T. L., Nuki, G., Pascual, E., Perez-Ruiz, F., Punzi, L., So, A. K., & Bardin, T. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201687 · Cited by 271
Perez-Ruiz, F., Alonso-Ruiz, A., Calabozo, M., Herrero-Beites, A., García-Erauskin, G., & Ruiz-Lucea, E. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.9.545 · Cited by 257
Major, T. J., Topless, R. K., Dalbeth, N., & Merriman, T. R. (2018) · BMJ · doi:10.1136/bmj.k3951 · Cited by 246
Self-citationSchlesinger, N., Mysler, E., Lin, H.-Y., De Meulemeester, M., Rovensky, J., Arulmani, U., Balfour, A., Krammer, G., Sallstig, P., & So, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.144063 · Cited by 244
Spencer, K., Carr, A., & Doherty, M. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200801 · Cited by 211
Purine-rich foods intake and recurrent gout attacks
Zhang, Y., Chen, C., Choi, H., Chaisson, C., Hunter, D., Niu, J., & Neogi, T. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201215 · Cited by 209
Self-citationQuality of care for gout in the US needs improvement
Singh, J. A., Hodges, J. S., Toscano, J. P., & Asch, S. M. (2007) · Arthritis Care & Research · doi:10.1002/art.22767 · Cited by 197
Self-citationSaag, K. G., Fitz‐Patrick, D., Kopicko, J., Fung, M., Bhakta, N., Adler, S., Storgard, C., Baumgartner, S., & Becker, M. A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39840 · Cited by 184
Miao, Y., Ottenbros, S. A., Laverman, G. D., Brenner, B. M., Cooper, M. E., Parving, H.-H., Grobbee, D. E., Shahinfar, S., de Zeeuw, D., & Lambers Heerspink, H. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.171488 · Cited by 182
Man, C. Y., Cheung, I. T. F., Cameron, P. A., & Rainer, T. H. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.11.014 · Cited by 177
Kanji, T., Gandhi, M., Clase, C. M., & Yang, R. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0047-z · Cited by 174
Schünemann, H. J., Mustafa, R. A., Brożek, J., Santesso, N. A., Bossuyt, P. M., Steingart, K. R., Leeflang, M., Lange, S., Trenti, T., Langendam, M. W., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.02.003 · Cited by 166
Self-citationDalbeth, N., Jones, G., Terkeltaub, R. A., Khanna, D., Kopicko, J., Bhakta, N., Adler, S. H., Fung, M. M., Storgard, C. M., Baumgartner, S., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40159 · Cited by 165
Self-citationNielsen, S. M., Bartels, E. M., Henriksen, M., Wæhrens, E. E., Gudbergsen, H., Bliddal, H., Astrup, A. V., Knop, F. K., Carmona, L., Taylor, W. J., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211472 · Cited by 164
Self-citationStamp, L. K., Chapman, P. T., Barclay, M. L., Horne, A. M., FRAMPTON, C. M. A., Tan, P., Drake, J. M., & Dalbeth, N. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210872 · Cited by 161
Self-citationReview: Treat to Target in Rheumatoid Arthritis: Fact, Fiction, or Hypothesis?
Solomon, D. H., Bitton, A., Katz, J. N., Radner, H., Brown, E. M., & Fraenkel, L. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38323 · Cited by 156
Solomon, D. H., Liu, C., Kuo, I.-H., Zak, A., & Kim, S. C. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207984 · Cited by 155
Self-citationLocal ice therapy during bouts of acute gouty arthritis.
Schlesinger, N., Detry, M. A., Holland, B. K., Baker, D. G., Beutler, A. M., Rull, M., Hoffman, B. I., & Schumacher, H. R. (2002) · PubMed · Cited by 145
Schlesinger, N., Meulemeester, M. D., Pikhlak, A., Yücel, E., Richard, D., Murphy, V., Arulmani, U., Sallstig, P., & So, A. K.-L. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3297 · Cited by 139
Taylor, T. H., Mecchella, J. N., Larson, R. J., Kerin, K., & MacKenzie, T. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.05.025 · Cited by 138
Zhang, M., Solomon, D. H., Desai, R. J., Kang, E. H., Liu, J., Neogi, T., & Kim, S. C. (2018) · Circulation · doi:10.1161/circulationaha.118.033992 · Cited by 137
Self-citationAlcohol Quantity and Type on Risk of Recurrent Gout Attacks: An Internet-based Case-crossover Study
Neogi, T., Chen, C. A., Niu, J., Chaisson, C. E., Hunter, D. J., & Zhang, Y. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.12.019 · Cited by 136
Self-citationAxelrod, D. R., & Preston, S. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310618 · Cited by 126
Terkeltaub, R. A., Schumacher, H. R., Carter, J. D., Baraf, H. S. B., Evans, R. R., Wang, J., King-Davis, S., & Weinstein, S. P. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4159 · Cited by 122
Yamanaka, H., Tamaki, S., Ide, Y., Kim, H., Inoue, K., Sugimoto, M., Hidaka, Y., Taniguchi, A., Fujimori, S., & Yamamoto, T. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211574 · Cited by 122
Schumacher, H. R., Evans, R. R., Saag, K. G., Clower, J. W., Jennings, W., Weinstein, S. P., Yancopoulos, G. D., Wang, J., & Terkeltaub, R. A. (2012) · Arthritis Care & Research · doi:10.1002/acr.21690 · Cited by 121
Tausche, A., Alten, R., Dalbeth, N., Kopicko, J., Fung, M. M., Adler, S. H., Bhakta, N., Storgard, C. M., Baumgartner, S., & Saag, K. G. (2017) · Rheumatology · doi:10.1093/rheumatology/kex350 · Cited by 121
Self-citationComparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis.
Alloway, J. A., Moriarty, M. J., Hoogland, Y. T., et al. (1993) · PubMed · Cited by 120
Paulus, H. E., Schlosstein, L. H., Godfrey, R. G., et al. (1974) · Arthritis & Rheumatism · doi:10.1002/art.1780170517 · Cited by 114
Khan, A. A., Quinn, T. J., Hewitt, J., Fan, Y., & Dawson, J. (2016) · AGE · doi:10.1007/s11357-016-9871-8 · Cited by 109
Long-term safety of pegloticase in chronic gout refractory to conventional treatment
Becker, M. A., Baraf, H. S. B., Yood, R. A., Dillon, A., Vázquez‐Mellado, J., Ottery, F. D., Khanna, D., & Sundy, J. S. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201795 · Cited by 107
Self-citationRashid, N., Coburn, B. W., Wu, Y., Cheetham, T. C., Curtis, J. R., Saag, K. G., & Mikuls, T. R. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.140588 · Cited by 104
Self-citationSiegel, L. B., Alloway, J. A., & Nashel, D. J. (1994) · PubMed · Cited by 103
Mitha, E., Schumacher, H. R., Fouche, L. F., Luo, S., Weinstein, S. P., Yancopoulos, G. D., Wang, J., King-Davis, S., & Evans, R. R. (2013) · Rheumatology · doi:10.1093/rheumatology/ket114 · Cited by 100
Effects of Febuxostat in Early Gout: A Randomized, Double‐Blind, Placebo‐Controlled Study
Dalbeth, N., Saag, K. G., Palmer, W. E., Choi, H. K., Hunt, B., MacDonald, P. A., Thienel, U., & Gunawardhana, L. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40233 · Cited by 98
Self-citationA two-stage approach to the treatment of hyperuricemia in gout: The “dirty dish” hypothesis
Pérez-Ruiz, F., Herrero-Beites, A. M., & Carmona, L. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30649 · Cited by 94
Baraf, H. S. B., Becker, M. A., Gutiérrez-Ureña, S. R., Treadwell, E. L., Vázquez‐Mellado, J., Rehrig, C. D., Ottery, F. D., Sundy, J. S., & Yood, R. A. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4318 · Cited by 93
Dalbeth, N., Chen, P., White, M., Gamble, G. D., Barratt-Boyes, C., Gow, P. J., & Orr‐Walker, B. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203970 · Cited by 90
Self-citationLiu, P., Wang, H., Zhang, F., et al. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.4310 · Cited by 87
Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial
Mikuls, T. R., Cheetham, T. C., Levy, G. D., Rashid, N., Kerimian, A., Low, K. J., Coburn, B. W., Redden, D. T., Saag, K. G., Foster, P., et al. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.11.011 · Cited by 87
Self-citationStamp, L. K., O'Donnell, J. L., FRAMPTON, C. M. A., Drake, J. M., Zhang, M., & Chapman, P. T. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37925 · Cited by 86
Self-citationDoes Starting Allopurinol Prolong Acute Treated Gout? A Randomized Clinical Trial
Hill, E. M., Sky, K., Sit, M., Collamer, A. N., & Higgs, J. B. (2015) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000235 · Cited by 86
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension study
Stamp, L. K., Chapman, P. T., Barclay, M. L., Horne, A. M., FRAMPTON, C. M. A., Tan, P., Drake, J. M., & Dalbeth, N. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211873 · Cited by 86
Self-citationJutkowitz, E., Dubreuil, M., Lu, N., Kuntz, K. M., & Choi, H. K. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.10.009 · Cited by 84
Goldfarb, D. S., MacDonald, P. A., Gunawardhana, L., Chefo, S., & McLean, L. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01760213 · Cited by 79
Poiley, J. E., Steinberg, A. S., Choi, Y., Davis, C. S., Martin, R. L., McWherter, C. A., Boudes, P. F., & for the Arhalofenate Flare Study Investigators (2016) · Arthritis & Rheumatology · doi:10.1002/art.39684 · Cited by 79
Sundy, J. S., Schumacher, H. R., Kivitz, A., Weinstein, S. P., Wu, R., King-Davis, S., & Evans, R. R. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.131226 · Cited by 75
Effect of Urate-lowering Therapies on Renal Disease Progression in Patients with Hyperuricemia
Levy, G. D., Rashid, N., Niu, F., & Cheetham, T. C. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.131159 · Cited by 75
Self-citationGoldfien, R. D., Pressman, A. R., Jacobson, A. S., Ng, M. S., & Avins, A. L. (2016) · The Permanente Journal · doi:10.7812/tpp/15-234 · Cited by 75
The effect of bariatric surgery on gout: a comparative study
Romero‐Talamás, H., Daigle, C. R., Aminian, A., Corcelles, R., Brethauer, S. A., & Schauer, P. R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.02.025 · Cited by 73
Strand, V., Khanna, D., Singh, J. A., Forsythe, A., & Edwards, N. L. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111375 · Cited by 73
Self-citationKeller, S. F., Lu, N., Blumenthal, K. G., Rai, S. K., Yokose, C., Choi, J. W. J., Kim, S. C., Zhang, Y., & Choi, H. K. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212905 · Cited by 69
Self-citationComprehensive dietary education in treated gout patients does not further improve serum urate
Holland, R., & McGill, N. W. (2014) · Internal Medicine Journal · doi:10.1111/imj.12661 · Cited by 67
Waldman, B., Ansquer, J.-C., SULLIVAN, D. R., Jenkins, A. J., McGill, N. W., Buizen, L., Davis, T. M. E., Best, J. D., Li, L., Feher, M. D., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30029-9 · Cited by 65
Schumacher, H. R., Berger, M. F., Li‐Yu, J., Pérez-Ruiz, F., Burgos‐Vargas, R., & Li, C. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110916 · Cited by 64
Defining certainty of net benefit: a GRADE concept paper
Alper, B. S., Oettgen, P., Kunnamo, I., Iorio, A., Ansari, M. T., Murad, M. H., Meerpohl, J. J., Qaseem, A., Hultcrantz, M., Schünemann, H. J., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027445 · Cited by 62
Self-citationPredicting allopurinol response in patients with gout
Wright, D. F. B., Duffull, S. B., Merriman, T. R., Dalbeth, N., Barclay, M. L., & Stamp, L. K. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12799 · Cited by 55
Self-citationFoody, J. M., Turpin, R. S., Tidwell, B. A., Lawrence, D. F. E., & Schulman, K. L. (2017) · Europe PMC (PubMed Central) · Cited by 46
Mechanism and treatment of hypertriglyceridaemia in gout.
Gibson, T., Kilbourn, K., Horner, I., et al. (1979) · Annals of the Rheumatic Diseases · doi:10.1136/ard.38.1.31 · Cited by 43
Obesity Paradox in Recurrent Attacks of Gout in Observational Studies: Clarification and Remedy
Nguyen, U., Zhang, Y., Louie‐Gao, Q., Niu, J., Felson, D. T., LaValley, M. P., & Choi, H. K. (2016) · Arthritis Care & Research · doi:10.1002/acr.22954 · Cited by 43
The Evidence Basis for the American College of Rheumatology Practice Guidelines
Duarte‐García, A., Zamore, R., & Wong, J. B. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6680 · Cited by 36
Alcohol and response to treatment of gout
Ralston, S. H., Capell, H. A., & Sturrock, R. D. (1988) · BMJ · doi:10.1136/bmj.296.6637.1641-a · Cited by 34
Yu, J., Qiu, Q., Liang, L., Yang, X., & Xu, H. (2017) · Modern Rheumatology · doi:10.1080/14397595.2017.1318467 · Cited by 34
Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout
FitzGerald, J. D., Mikuls, T. R., Neogi, T., Singh, J. A., Robbins, M., Khanna, P. P., Turner, A. S., Myslinski, R., & Suter, L. G. (2018) · Arthritis Care & Research · doi:10.1002/acr.23500 · Cited by 31
Self-citationUrate-Lowering Therapy in Moderate to Severe Chronic Kidney Disease
Levy, G. D., Shi, J. M., Cheetham, T. C., & Rashid, N. (2018) · The Permanente Journal · doi:10.7812/tpp/17-142 · Cited by 29
Self-citationHirsch, J. D., Gnanasakthy, A., Lale, R., Choi, K., & Sarkin, A. J. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12521 · Cited by 16
Outcome Measures for Gout Clinical Trials: a Summary of Progress
de Lautour, H., Dalbeth, N., & Taylor, W. J. (2015) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-015-0014-7 · Cited by 9
Self-citationWarrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment
Gherghina, M.-E., Peride, I., Tiglis, M., Neagu, T. P., Niculae, A., & Checherita, I. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063188 · Cited by 501
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis
Kimura, Y., Tsukui, D., & Kono, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212394 · Cited by 309
Metadata
- Authors
- FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello‐Petersen, R., Guyatt, G., Abeles, A. M., Gelber, A. C., Harrold, L. R., Khanna, D., King, C., Levy, G., Libbey, C., Mount, D., Pillinger, M. H., Rosenthal, A., Singh, J. A., Sims, J. E., Smith, B. J., Wenger, N. S., Bae, S. S., Danve, A., Khanna, P. P., Kim, S. C., Lenert, A., Poon, S., Qasim, A., Sehra, S. T., Sharma, T. S. K., Toprover, M., Turgunbaev, M., Zeng, L., Zhang, M. A., Turner, A. S., & Neogi, T.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2020-05-11
- Volume
- 72
- Issue
- 6
- Pages
- 744-760
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W4229537562
- Cited by
- 983
- References
- 103
- FWCI
- 61.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.